Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis
Public ClinicalTrials.gov record NCT05671835. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
REVERT-IPF: A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the safety and tolerability of oral daily administration of TTI-101 over a 12-week treatment duration in participants with idiopathic pulmonary fibrosis (IPF).
Study identification
- NCT ID
- NCT05671835
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 15, 2023 (Actual)
- Primary completion
- Aug 14, 2025 (Actual)
- Completion
- Aug 14, 2025 (Actual)
- Last update posted
- Aug 13, 2026
2023 – 2025
United States locations
- U.S. sites
- 28
- U.S. states
- 16
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Kirklin Clinic of University of Alabama Birmingham Hospital | Birmingham | Alabama | 35233 | — |
| University of California San Diego | La Jolla | California | 92037 | — |
| University of California Irvine (UCI) Health | Orange | California | 92868 | — |
| University of Colorado School of Medicine | Aurora | Colorado | 80045 | — |
| Saint Francis Sleep Allergy and Lung Institute | Clearwater | Florida | 33765 | — |
| University of Florida | Gainesville | Florida | 32610 | — |
| UHealth - University of Miami Health Systems | Miami | Florida | 33125 | — |
| Emory University Hospital | Atlanta | Georgia | 30322 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| University of Chicago Medicine | Chicago | Illinois | 60637 | — |
| Loyola University Medical Center | Maywood | Illinois | 60153 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | — |
| Tulane University School of Medicine | New Orleans | Louisiana | 70112-2600 | — |
| The Lung Research Center | Chesterfield | Missouri | 63017 | — |
| New York University Langone Pulmonary and Critical Care Associates | Brooklyn | New York | 10017 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| Pulmonix | Greensboro | North Carolina | 27403 | — |
| Salem Chest Specialists | Winston-Salem | North Carolina | 27103-4007 | — |
| Saint Luke's University Hospital - Bethlehem | Bethlehem | Pennsylvania | 18020 | — |
| Penn State Health Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033 | — |
| Temple University Hospital | Philadelphia | Pennsylvania | 19140 | — |
| The Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Clinical Trials Center of Middle Tennessee | Franklin | Tennessee | 37067 | — |
| Baylor Scott & White Center for Advanced Heart & Lung Disease | Dallas | Texas | 75246 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| University of Texas Health Science Center at Houston (UT Health) | Houston | Texas | 77030 | — |
| Metroplex Pulmonary and Sleep Center | McKinney | Texas | 75069 | — |
| Inova Fairfax Medical Campus | Falls Church | Virginia | 22042 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05671835, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 13, 2026 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05671835 live on ClinicalTrials.gov.